EDITOR'S PAGE: Advances in Drug Delivery
Robert L. Avery, MD, Associate Medical Editor, Allen C. Ho, MD, Chief Medical Editor
May/June 2010 | News Feature
The Potential Role of Regenerative Medicine in Ophthalmology
Pfizer is investing resources and scientific know-how to develop stem-cell therapies for retinal diseases.
Jennifer Kreatsoulas, PHD, Senior Associate Editor
May/June 2010 | Business Of Retina
FELLOWS' FOCUS: Tips for the New Retina Attending
Darrell E. Baskin, MD; Chirag P. Shah, MD, MPH; and Jeremy D. Wolfe, MD
RETINA IN THE ASC: Efficiency in the ASC: A Team Effort
At Spectra Eye Institute, we strive toward the common goal of excellent patient care.
Jan Amator, MBA
May/June 2010 | Retina Surgery
GLOBAL PERSPECTIVES: German Organization Advocates for Ophthalmic Surgeons' Interests
The BDOC, an ophthalmic professional organization in Germany, negotiates contracts with health insurance companies and advocates for governmental policies that affect its members.
With Armin Scharrer, MD
RETINA PEARLS: Incision-related Complications of Sutureless Vitrectomy
Rare complications of vitrectomy with small-gauge instrumentation can significantly affect vision.
Susanne Binder, MD
SURGICAL UPDATES: Pars Plana Vitrectomy and Lensectomy with a 23-gauge Vitrectomy System
Aziz A. Khanifar, MD; Harry K. Roux, MD; and R.V. Paul Chan, MD
May/June 2010 | Oncology
CASE REPORTS IN OCULAR ONCOLOGY: Uveal Coloboma: The Related Syndromes
Irina Belinsky, MD; Aparna Ramasubramanian, MD; Neelema Sinha, MD; and Carol Shields, MD
May/June 2010 | Cover Stories
Sustained- release Corticosteroid Delivery Systems
Implant technology offers promising solutions to the burden of repeated injections for retinal diseases.
Szilard Kiss, MD
Topical Drug Delivery for Posterior Segment Disease
Novel formulations offer possibilities for efficacious therapies through topical routes.
Daniel F. Kiernan, MD, and Jennifer I. Lim, MD
Update on Endophthalmitis After Anti-VEGF Injection
Standardized preparation may be a factor in low infection rate.
Andrew A. Moshfeghi, MD, MBA
A New Target for Neovascular AMD
This molecule might enable earlier detection of neovascularization.
Jayakrishna Ambati, MD
Sustained Drug-delivery for Retinal Disease
Current technologies include implanted and injected devices.
Glenn J. Jaffe, MD
May/June 2010 | Oncology Feature
Von Hippel-Lindau Disease
A review of the physiopathlology, epidemiology, diagnosis, and treatment for this rare condition.
Hadas Newman, MD, and Paul T. Finger, MD
May/June 2010 | Medical Retina Feature
Combination Therapy for RVO
The complexity of this multifactorial disease state suggests a need for a tailored treatment approach.
Seenu M. Hariprasad, MD; Veeral Sheth, MD; and Paulpoj Chiranand, MD
May/June 2010 | Retinal Imaging Feature
Imaging and Pharmacologic Approaches in the Treatment of Geographic Atrophy in AMD
Imaging with FAF offers new insight into how and why GA progresses in some patients.
Frank G. Holz, MD
5 Questions with Peter K. Kaiser, MD
Dr. Kaiser is a Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine and a staff surgeon in the Vitreoretinal Department at the Cole Eye Institute, Cleveland Clinic. He is the Founding Director of the Digital Optical Coherence Tomography Reading Center (DOCTR) at the Cole Eye Institute.